|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4545 | |
| A61K 31/427 | |||
| A61K 38/21 | |||
| A61K 45/00 | |||
| A61K 9/14 | |||
| A61K 9/48 | |||
| A61K 9/20 | |||
| A61P 31/12 |
| (11) | Number of the document | 3370723 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16862727.1 |
| Date of filing the European patent application | 2016-10-26 | |
| (97) | Date of publication of the European application | 2018-09-12 |
| (45) | Date of publication and mention of the grant of the patent | 2020-12-16 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/058937 |
| Date | 2016-10-26 |
| (87) | Number | WO 2017/079009 |
| Date | 2017-05-11 |
| (30) | Number | Date | Country code |
| 201562251026 P | 2015-11-04 | US | |
| 201662297740 P | 2016-02-19 | US | |
| 201662321623 P | 2016-04-12 | US |
| (72) |
CORY, David A., US
CHOONG, Ingrid, US
GLENN, Jeffrey S., US
|
| (73) |
Eiger Biopharmaceuticals, Inc.,
2155 Park Boulevard, Palo Alto, CA 94306,
US
|
| (54) | TREATMENT OF HEPATITIS DELTA VIRUS INFECTION |
| TREATMENT OF HEPATITIS DELTA VIRUS INFECTION |